![]() |
|
October 27, 2008 | |
MARK YOUR CALENDARS- Case CCC Scientific Retreat 2009The Case CCC Scientific Retreat has been scheduled for July 10-11, 2009 at Sawmill Creek Resort in Huron, Ohio. We hope everyone is able to attend. Details will be released in the coming months. CTSC PILOT PROJECT AWARDEESCongratulations to the following Cancer Center members who were recently awarded pilot project grants from the Case Western University Clinical and Translational Science Collaborative (CTSC): For more information about the CTSC and these pilot projects, please click here. GABRIELLE BRETT NAMED OUTSTANDING CANCER PROFESSIONAL BY OHIO PARTNERS FOR CANCER CONTROLGabrielle Brett received the 2008 J. Nick Baird Outstanding Cancer Professional Award from the Ohio Partners for Cancer Control at its October 17 annual meeting. Ms. Brett is the Northern Ohio Partnership Program Coordinator for the National Cancer Institute's Cancer Information Service (CIS), a position funded by the NCI. The award honors Ms. Brett for "actively promoting and putting into practice the goals of the Ohio Cancer Plan" and acknowledges her commitment to "making cancer history for all Ohioans." She devotes much of her effort to reducing health disparities by reaching minorities and medically underserved populations with cancer information. Ms. Brett supports more than 30 Ohio and regional cancer organizations, health professionals, community groups and coalitions in 11 counties. Her home office is at the Ireland Cancer Center of University Hospitals Case Medical Center in Cleveland. Ireland Cancer Center Director Stanton L. Gerson, MD, nominated Ms. Brett for the award, saying, "Although she is not a cancer center employee, we are well aware of Ms. Brett's regional outreach initiatives to provide NCI information on cancer prevention, treatment and research and network building. We are lucky to have her striving to reduce the cancer burden throughout the state." Of her work, Ms. Brett says, "Information is key when it comes to improving cancer outcomes or making decisions about risk reduction, as I know all too well. I am thrilled to be in a position where I can share that information with organizations and community members, and I hope that our combined efforts will have a lasting impact." Ms. Brett and her husband live in Cleveland Heights. --Written by Pat Faller MESSAGE FROM NCI- New Clinical Trials Reporting Requirements Take Effect January 2009The National Cancer Institute (NCI) announces a change in how clinical trials and studies are registered and reported and will launch its Clinical Trials Reporting Program (CTRP) on January 5, 2009. NCI grantees are currently subject to reporting requirements, but starting in 2009, a new set of reporting requirements will apply. Additional registration is not required for trials already reported to CTEP/DCP as NCI will transfer the information. Starting in January 2009, grantees are to register all new interventional trials and observational studies within 21 days of activation using an online portal or an automated batch upload system. Requested data elements are similar to the ones grantees currently complete for NCI. In addition, grantees will upload supporting documents such as the protocol document, informed consent, IRB approval and a list of participating sites for multi-center studies. Also, over the first six months of 2009, grantees are to register all ongoing interventional trials and observational studies. For the second half of 2009 and onward, grantees are to electronically submit data from all NCI-funded and sponsored trials and studies that have been registered in the CTRP at intervals specified in the data reporting mechanism. Data will include, but not be limited to, trial and study amendments and select patient demographics. The CTRP goal is to provide NCI with a more global view of emerging knowledge from cancer trials and to identify important patterns and insights in a timely way in order to assure patient safety and an optimal return on the nation's investment in cancer clinical trials. This goal enhances NCI's commitment to protecting human research participants in NCI-supported trials, safeguarding the integrity of the data resulting from this research, and applying measures that enable effective monitoring of research. More detailed information about the CTRP requirements will follow through December 2008. For more information about this program please click here. FUNDING OPPORTUNITY– ASCO Cancer Foundation Translational Research ProfessorshipThe ASCO Cancer Foundation is accepting applications for the Translational Research Professorship. This Professorship provides funds to translational researchers who have made significant contributions to the direction of cancer research. Furthermore, it is expected that these researchers will continue to provide leadership in their research area. In general, applicants must hold the rank of full professor (or equivalent) at an academic medical center. Letter of Intent Deadline: November 20 For details, please click here. FUNDING OPPORTUNITY– American Cancer Society (ACS) Audrey Meyer Mars International Fellowships in Clinical OncologyThe purpose of the Fellowships is to provide one year of advanced training in clinical oncology at participating cancer centers in the United States to qualified physicians and dentists from other countries, particularly countries where advanced training is not readily available. Applications for training in basic cancer research will not be accepted for the award. Institutions, not prospective trainees, must submit applications for the American Cancer Society (ACS) Audrey Meyer Mars International Fellowships in Clinical Oncology. If you have someone you would like to nominate for this opportunity, please contact gillian.irwin@case.edu Internal Deadline: November 14 For eligibility and other information, please click here. FUNDING OPPORTUNITY– Charlotte Geyer FoundationThe Charlotte Geyer Foundation provides interim funding up to $100,000 to researchers who have submitted an original R01 or R21 proposal to the National Cancer Institute and have not received a fundable score. Researchers may apply to the Foundation as soon as NCI Summary Statements are received and before the proposal goes to Council. Deadline: November 15 For details, please click here. |
EVENTS**All events are open to anyone interested in attending October 27Case CCC and Neurosciences Faculty Candidate Seminar Hematology/Oncology Research In Progress Seminar Pathology Research Seminar Series Physiology & Biophysics Seminar October 28Taussig Cancer Institute Core Curriculum Series October 29Grand Rounds October 30TREC Seminar cancelled Taussig Cancer Institute Core Curriculum Series Neurosciences Seminar Greenfield Lecture in Pharmacology Practice-Based Research Network Seminar October 31Taussig Cancer Institute Grand Rounds cancelled- SWOG Hematology/Oncology Fellows Cancer Center Seminar Series/ Blood Club more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMS**For more information on these symposiums, please contact Christine Rhoads. Family-Centered Care Head and Neck Conference Ohio Collaborative Conference on Bioinformatics (OCCBIO) Annual Breast Cancer Update: Highlights of the National Meetings |
NCI CANCER BULLETINFeatured Article Cancer Research Highlights Director's Update FUNDING OPPORTUNTY– Breast Cancer Research ProgramThe Department of Defense recently released the Program Announcement for the Breast Cancer Research Program (BCRP) FY08 Concept Award and Postdoctoral Award. Concept Award Pre-Application Deadline: November 6 For more information, please click here. Postdoctoral Award Under this award mechanism, the postdoctoral trainee is considered the Principal Investigator (PI) and, as such, should write the project narrative with appropriate direction from the mentor. While the PI is not required to have previous experience in breast cancer research, this proposal must focus on breast cancer research. The mentor must possess the appropriate expertise in breast cancer, have current peer reviewed breast cancer funding, and clearly demonstrate a commitment to guiding the PI's research and training. Postdoctoral Award proposals should either extend the candidate's ongoing research related to breast cancer, or broaden the scope of his or her research to include work that is highly relevant to breast cancer, under the guidance of a designated mentor. Proposals with a multidisciplinary research approach to breast cancer are highly encouraged but not required. Pre-application submission: November 19 For more information, please click here. FUNDING OPPORTUNITY– 2009 Dana Foundation Brain and Immuno-Imaging Grant ProgramCWRU has been invited to apply for the 2009 Dana Foundation Brain and Immuno-Imaging Grant Program. This program focuses on improving human brain and brain-immune function in health and disease. CWRU may submit TWO applications: ONE for Track A, and ONE for Track B: Track A: Conventional imaging of anatomical or physiological brain functioning; should involve patient-oriented clinical research. If you are interested in participating in the CWRU internal competition, please send the following materials electronically to Ann Tillett at axt83@case.edu: For program details, please click here. Internal Deadline: October 31 If you have any questions regarding this internal competition and/or the application requirements, please contact Richard Sohn at Richard.sohn@case.edu or 368-1158. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESChemical Biology Consortium |
NIH Bulletin – Notices and Funding OpportunitiesPilot Studies: Oral Complications of Cancer Therapies (R21) Cancer Disparities Research Partnership (CDRP) Program: Limited Competition (U54) (RFA-CA-09-502) Basic and Preclinical Research on Complementary and Alternative Medicine (CAM) (R01) (PA-09-010) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Hassinger 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.hassinger@uhhospitals.org |
|
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |